Cause of death, by non-communicable diseases, ages 5-14, male in Niger
Niger: Cause of death, by non-communicable diseases, ages 5-14, male was 15.9% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, male in Niger, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 5-14.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 5-14, male in Niger stood at 15.9%. That is the highest value across all 6 years on record.
The figure is up 2.3% on the previous year and up 16.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, male in Niger peaked at 15.9% in 2021 and was at its lowest, 13.4%, in 2000.
Niger ranks 166th of 185 countries on this measure, in the bottom quarter.
Cause of death, by non-communicable diseases, ages 5-14, male in Niger, year by year
| Year | % of total male deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 13.4% | — |
| 2010 | 13.7% | +2.1% |
| 2015 | 15.8% | +15.3% |
| 2019 | 15.9% | +0.5% |
| 2020 | 15.6% | -1.8% |
| 2021 | 15.9% | +2.3% |
Niger compared with similar countries
- Niger's 15.9% is below the median for low income countries, which is 18.9%, 84% of the median. (25 countries reporting)
- Niger's 15.9% is below the median for Sub-Saharan Africa, which is 17.0%, 94% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 13.4% | 13.4% | 13.4% | 1 |
| 2010s | 15.1% | 13.7% | 15.9% | 3 |
| 2020s | 15.8% | 15.6% | 15.9% | 2 |
Countries ranked near Niger
More health data for Niger
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.35 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 22,995 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 15 (2025)
- Population ages 00-04, female, annual growth rate 2.54 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0865 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.53 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, male in Niger?
- Cause of death, by non-communicable diseases, ages 5-14, male in Niger was 15.9% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, male recorded in Niger?
- The highest recorded value was 15.9% in 2021.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, male recorded in Niger?
- The lowest recorded value was 13.4% in 2000.
- How does Niger rank for cause of death, by non-communicable diseases, ages 5-14, male?
- Niger ranks 166th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, male rising or falling in Niger?
- Over the last ten years it is up 16.5%. The long-run trend across the full record is rising.
- Where does this Niger data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.